Book contents
- The Obstetric Hematology Manual
- The Obstetric Hematology Manual
- Copyright page
- Dedication
- Contents
- Contributors
- Preface to the Second Edition
- Section 1 Physiological Changes in Pregnancy
- Section 2 Cytopenia
- Section 3 Inherited Red Cell Disorders
- Section 4 Fetal Maternal Alloimmune Syndromes
- Section 5 Thromboembolism and Anticoagulation
- Section 6 Thrombophilia and Fetal Loss
- Section 7 Hemorrhagic Disorders
- Section 8 Microangiopathies
- Chapter 22 Pre-eclampsia
- Chapter 23 Thrombotic Thrombocytopenic Purpura and Other Microangiopathies in Pregnancy
- Section 9 Malignant Conditions
- Index
- References
Chapter 23 - Thrombotic Thrombocytopenic Purpura and Other Microangiopathies in Pregnancy
from Section 8 - Microangiopathies
Published online by Cambridge University Press: 01 February 2018
Book contents
- The Obstetric Hematology Manual
- The Obstetric Hematology Manual
- Copyright page
- Dedication
- Contents
- Contributors
- Preface to the Second Edition
- Section 1 Physiological Changes in Pregnancy
- Section 2 Cytopenia
- Section 3 Inherited Red Cell Disorders
- Section 4 Fetal Maternal Alloimmune Syndromes
- Section 5 Thromboembolism and Anticoagulation
- Section 6 Thrombophilia and Fetal Loss
- Section 7 Hemorrhagic Disorders
- Section 8 Microangiopathies
- Chapter 22 Pre-eclampsia
- Chapter 23 Thrombotic Thrombocytopenic Purpura and Other Microangiopathies in Pregnancy
- Section 9 Malignant Conditions
- Index
- References
- Type
- Chapter
- Information
- The Obstetric Hematology Manual , pp. 282 - 292Publisher: Cambridge University PressPrint publication year: 2018
References
Rangarajan, S, Kessler, C, Aledort, L. The clinical implications of ADAMTS13 function: the perspectives of hemostaseologists. Thrombosis Research 2013; 132(4): 403–407.Google Scholar
Delmas, Y, Helou, S, Chabanier, P et al. Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease. BMC Pregnancy Childbirth 2015; 15: 137.CrossRefGoogle Scholar
Velauthar, L, Plana, MN, Kalidindi, M et al. First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55,974 women. Ultrasound in Obstetrics and Gynecology 2014; 43(5): 500–507.Google Scholar
Naljayan, MV, Karumanchi, SA. New developments in the pathogenesis of preeclampsia. Advances in Chronic Kidney Disease 2013; 20(3): 265–270.Google Scholar
Scully, M, Hunt, BJ, Benjamin, S et al. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. British Journal of Haematology 2012; 158(3): 323–335.Google Scholar
Sadler, JE. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood 2008; 112(1): 11–18.CrossRefGoogle ScholarPubMed
Moatti-Cohen, M, Garrec, C, Wolf, M et al. Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura. Blood 2012; 119(24): 5888–5897.CrossRefGoogle ScholarPubMed
Scully, M, Thomas, M, Underwood, M et al. Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes. Blood 2014; 124(2): 211–219.CrossRefGoogle ScholarPubMed
Sanchez-Luceros, A, Farias, CE, Amaral, MM et al. von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women. Thrombosis and Hemostasis 2004; 92(6): 1320–1326.Google ScholarPubMed
Lattuada, A, Rossi, E, Calzarossa, C et al. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome. Hematologica 2003; 88(9): 1029–1034.Google ScholarPubMed
Narayanan, P, Jayaraman, A, Rustagi, RS et al. Rituximab in a child with autoimmune thrombotic thrombocytopenic purpura refractory to plasma exchange. International Journal of Hematology 2012; 96(1): 122–124.Google Scholar
Shamseddine, A, Saliba, T, Aoun, E et al. Thrombotic thrombocytopenic purpura: 24 years of experience at the American University of Beirut Medical Center. Journal of Clinical Apheresis 2004; 19(3): 119–124.Google Scholar
Ozkan, S, Ceylan, Y, Ozkan, OV et al. Review of a challenging clinical issue: Intrahepatic cholestasis of pregnancy. World Journal of Gastroenterology 2015; 21(23): 7134–7141.Google Scholar
Kia, L, Rinella, ME. Interpretation and management of hepatic abnormalities in pregnancy. Clinical Gastroenterology and Hepatology 2013; 11(11): 1392–1398.CrossRefGoogle ScholarPubMed
Sibai, BM. Imitators of severe preeclampsia. Obstetrics and Gynecology 2007; 109(4): 956–966.Google Scholar
Caprioli, J, Noris, M, Brioschi, S et al. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 2006; 108(4): 1267–1279.Google Scholar
Fakhouri, F, Vercel, C, Fremeaux-Bacchi, V. Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy. Clinical Journal of the American Society of Nephrology 2012; 7(12): 2100–2106.Google Scholar
Tsai, HM. Autoimmune thrombotic microangiopathy: advances in pathogenesis, diagnosis, and management. Seminars in Thrombosis and Hemostasis 2012; 38: 469–482.Google Scholar
Panelius, J, Meri, S. Complement system in dermatological diseases – fire under the skin. Frontiers of Medicine 2015; 2: 3. https://doi.org/10.3389/fmed.2015.00003.Google ScholarPubMed